Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Other Working Capital Changes (2016 - 2025)

Amicus Therapeutics (FOLD) has disclosed Other Working Capital Changes for 16 consecutive years, with $595000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Working Capital Changes fell 95.83% year-over-year to $595000.0, compared with a TTM value of $1.4 million through Dec 2025, up 109.9%, and an annual FY2025 reading of $1.4 million, up 109.9% over the prior year.
  • Other Working Capital Changes was $595000.0 for Q4 2025 at Amicus Therapeutics, up from -$7.6 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $15.0 million in Q4 2021 and bottomed at -$19.3 million in Q2 2024.
  • Average Other Working Capital Changes over 5 years is $379800.0, with a median of $856500.0 recorded in 2022.
  • Peak annual rise in Other Working Capital Changes hit 1147.46% in 2023, while the deepest fall reached 3037.48% in 2023.
  • Year by year, Other Working Capital Changes stood at $15.0 million in 2021, then plummeted by 95.93% to $611000.0 in 2022, then plummeted by 3037.48% to -$17.9 million in 2023, then soared by 179.42% to $14.3 million in 2024, then tumbled by 95.83% to $595000.0 in 2025.
  • Business Quant data shows Other Working Capital Changes for FOLD at $595000.0 in Q4 2025, -$7.6 million in Q3 2025, and $4.8 million in Q2 2025.